Anal | Maryland Oncology Hematology Anal – Maryland Oncology Hematology

Trial ID ESR 22-21698 (EIMPRIS)

NCT05438498
clinicaltrials.gov ID
Phase II/III

Trial ID 20189

NCT04472429
clinicaltrials.gov ID
USOR ID: 20189 Phase III
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology